Precigen (PGEN) FY2019 results: revenue $91 million, down 40.0% on the year
Precigen, Inc. (PGEN) reported revenue of $91 million for fiscal 2019, the year ended 31 December 2019, down 40.0% on the year before. Net income was -$322 million, and diluted earnings per share $-2.09. The figures are the company's own, from the 10-K it filed with the SEC on 2 March 2020.
Revenue
$91 million
-40.0% on the year
FY2012FY2019
Operating margin
n/a
-334.4% a year earlier
FY2012FY2019
Net income
-$322 million
FY2012FY2019
Diluted EPS
-$2.09
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
90.7
151
219
-40.0%
Cost of revenue
n/a
n/a
62.8
Research and development
n/a
405
143
Selling, general and administrative
n/a
138
146
Operating income
n/a
-506
-138
Operating margin
n/a
-334.4%
-62.8%
Interest expense
n/a
8.5
0.6
Pre-tax income
-171
-396
-78.4
Income tax
-0.9
-15.4
2.1
Net income
-322
-509
-117
Net margin
-355.3%
-336.9%
-53.3%
Diluted EPS
-$2.09
-$3.93
-$0.98
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
-136
-124
-104
Capital expenditure
37.9
41.6
46.7
-8.9%
Free cash flow
-174
-166
-150
Free cash flow margin
-191.6%
-109.7%
-68.5%
Cash from investing
86.9
-151
104
Cash from financing
8.1
310
4.3
-97.4%
Depreciation and amortisation
24.9
33.1
31.1
-24.8%
Share-based compensation
18.9
36.3
41.6
-47.8%
Diluted shares, weighted
154m
n/a
n/a
Shares outstanding at period end
163m
160m
122m
+2.0%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
71.7
363
534
-80.2%
Non-controlling interest
0.0
15.9
12.9
Debt
220
212
8.0
+3.8%
Operating lease liabilities
10.1
0.0
n/a
Other liabilities
154
126
292
+22.6%
Total liabilities and equity
456
716
847
-36.4%
Fixed assets
44.0
86.9
113
-49.4%
Goodwill
54.1
93.6
93.8
-42.2%
Intangible assets
68.3
89.0
233
-23.2%
Investments
9.3
120
6.3
-92.3%
Cash and equivalents
65.8
96.9
68.1
-32.1%
Receivables
20.6
21.2
19.8
-2.6%
Other assets
194
209
313
-7.3%
Total assets
456
716
847
-36.4%
10-K for the year ended 31 December 2019, filed 2 March 2020: the filing.